BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Suzuki T, Matsushima M, Masui A, Tsuda S, Imai J, Nakamura J, Tsukune Y, Uchida T, Yuhara H, Igarashi M, Koike J, Mine T. Irsogladine maleate and rabeprazole in non-erosive reflux disease: A double-blind, placebo-controlled study. World J Gastroenterol 2015; 21(16): 5023-5031 [PMID: 25945018 DOI: 10.3748/wjg.v21.i16.5023]
URL: https://www.wjgnet.com/1007-9327/full/v21/i16/5023.htm
Number Citing Articles
1
Davide Giuseppe Ribaldone, Pendlimari Rajesh, Divya Chandradhara, Marco Astegiano, Rinaldo Pellicano. A randomized, double-blind, placebo-controlled pilot study to evaluate the efficacy and tolerability of a novel oral bioadhesive formulation for the treatment of nonerosive reflux disease-related symptomsEuropean Journal of Gastroenterology & Hepatology 2021; 32(2): 163 doi: 10.1097/MEG.0000000000001888
2
Xiaosi Zhang, Yuan Cheng, Xiaohong Li, Xiang Tan, Lei Shi, Xiaojun Shi, Xiancui Zhang, Chun’e Xie, Junxiang Li. Efficacy and safety of the Chinese herbal formula Hewei Jiangni recipe for NERD with cold-heat complex syndrome: study protocol for a double-blinded randomized controlled trialTrials 2021; 22(1) doi: 10.1186/s13063-021-05471-7
3
Enrico Stefano Corazziari, Antonio Gasbarrini, Lucia D'Alba, Valeria D'Ovidio, Oliviero Riggio, Sandro Passaretti, Bruno Annibale, Michele Cicala, Alessandro Repici, Gabrio Bassotti, Carolina Ciacci, Antonio Di Sabatino, Matteo Neri, Maria Consiglia Bragazzi, Emanuela Ribichini, Giulia Radocchia, Paola Iovino, Massimiliano Marazzato, Serena Schippa, Danilo Badiali. Poliprotect vs Omeprazole in the Relief of Heartburn, Epigastric Pain, and Burning in Patients Without Erosive Esophagitis and Gastroduodenal Lesions: A Randomized, Controlled TrialAmerican Journal of Gastroenterology 2023; 118(11): 2014 doi: 10.14309/ajg.0000000000002360
4
Jason Abdallah, Ronnie Fass. Gastrointestinal Motility Disorders2018; : 109 doi: 10.1007/978-3-319-59352-4_10
5
Margherita SARACCO, Vincenzo SAVARINO, Giorgia BODINI, Giorgio M. SARACCO, Rinaldo PELLICANO. Gastroesophageal reflux disease: key messages for cliniciansMinerva Gastroenterology 2022; 67(4) doi: 10.23736/S2724-5985.20.02783-X
6
Zhiwei Hu, Jimin Wu, Zhonggao Wang, Xinghua Bai, Yu Lan, Kefang Lai, Abudureyimu Kelimu, Feng Ji, Zhenling Ji, Diyu Huang, Zhiwei Hu, Xiaohua Hou, Jianyu Hao, Zhining Fan, Xiaoping Chen, Dong Chen, Shengliang Chen, Jinrang Li, Junxiang Li, Lan Li, Peng Li, Zhigang Li, Lin Lin, Bianying Liu, Dian-gang Liu, Yiping Lu, Bin Lü, Qiuping Lü, Ming Qiu, Zhongmin Qiu, Huajao Shen, Jun Tai, Yanping Tang, Wen Tian, Zhonghao Wang, Bangmao Wang, Jian-an Wang, Ju Wang, Qi Wang, Songling Wang, Wen Wang, Zhifei Wang, Wei Wei, Zhiwei Wu, Wei Wu, YanQiao Wu, Yu Wu, Jixiang Wu, Yinglian Xiao, Wen Xu, Xiwei Xu, Fuquan Yang, HuiQi Yang, Yunsheng Yang, Qiyuan Yao, Chunzhao Yu, Peng Zhang, Xiaolan Zhang, Taicheng Zhou, Duowu Zou. Chinese consensus on multidisciplinary diagnosis and treatment of gastroesophageal reflux disease 2022Gastroenterology & Endoscopy 2023; 1(2): 33 doi: 10.1016/j.gande.2023.01.001
7
L. Hillman, R. Yadlapati, A. J. Thuluvath, M. A. Berendsen, J. E. Pandolfino. A review of medical therapy for proton pump inhibitor nonresponsive gastroesophageal reflux diseaseDiseases of the Esophagus 2017; 30(9): 1 doi: 10.1093/dote/dox055
8
Jong M. Park, Ho J. Lee, Predrag Sikiric, Ki B. Hahm. BPC 157 Rescued NSAID-cytotoxicity Via Stabilizing Intestinal Permeability and Enhancing CytoprotectionCurrent Pharmaceutical Design 2020; 26(25): 2971 doi: 10.2174/1381612826666200523180301
9
V. Savarino, F. Pace, C. Scarpignato. Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non‐erosive reflux disease – efficacy of Esoxx, a hyaluronic acid–chondroitin sulphate based bioadhesive formulationAlimentary Pharmacology & Therapeutics 2017; 45(5): 631 doi: 10.1111/apt.13914
10
Antonio Ruiz de León San Juan, Julio Pérez de la Serna Bueno, María Concepción Sevilla Mantilla, José Miguel Esteban López-Jamar, Andrés Sánchez Pernaute. GASTRO-ESOPHAGEAL REFLUX DISEASE: LIMITS OF MEDICAL TREATMENT AND SURGICAL INDICATIONSRevista Española de Enfermedades Digestivas 2020;  doi: 10.17235/reed.2020.7648/2020
11
Daniela Jodorkovsky, John W. Blackett. Laryngopharyngeal and Gastroesophageal Reflux2020; : 271 doi: 10.1007/978-3-030-48890-1_30